101 results
Page 5 of 6
424B5
eog103 b2ikr4k
7 Oct 15
Prospectus supplement for primary offering
12:00am
8-K
EX-1.1
4t9llv
7 Oct 15
Contravir Pharmaceuticals, Inc. Announces Proposed Public Offering of Common Stock and Warrants to Purchase Common Stock
12:00am
8-K
EX-10.1
u7aah
15 Jan 15
ContraVir Pharmaceuticals Appoints John Sullivan-Bolyai, M.D., MPH, as Chief Medical Officer
12:00am
DEF 14A
acnq2ia5ae cxfj5hs8
27 Oct 14
Definitive proxy
12:00am
PRER14A
3u6jcbxcl8ss601466k
23 Oct 14
Preliminary revised proxy
12:00am
10-K
ghvdm2 d9uwtuob3mco9
29 Sep 14
Annual report
12:00am
8-K
EX-10.1
n0gvzd
26 Jun 14
Departure of Directors or Certain Officers
12:00am
8-K
EX-10.1
sa6xyt5j4wlta hrad6h
20 Mar 14
ContraVir Appoints James Sapirstein as Chief Executive Officer and Board Member
12:00am
10-12G/A
EX-99.1
nuwvgcjdh
6 Feb 14
Registration of securities (amended)
12:00am
10-12G/A
EX-99.1
2k0gc7m
24 Dec 13
Registration of securities (amended)
12:00am
10-12G/A
EX-10.5
1wp7g9ejmj2 7qtu
21 Nov 13
Registration of securities (amended)
12:00am
10-12G/A
EX-99.1
jhooixbluy0ud hebk
21 Nov 13
Registration of securities (amended)
12:00am
10-12G/A
EX-99.1
c0lwqf8oxn8imb3
22 Oct 13
Registration of securities (amended)
12:00am
10-12G/A
EX-99.1
5x43oqevt 60epuh
20 Sep 13
Registration of securities (amended)
12:00am
10-12G
EX-3.1
4h0r u7kz4
8 Aug 13
Registration of securities
12:00am
10-12G
EX-10.2
0lppe5mo3 95
8 Aug 13
Registration of securities
12:00am
10-12G
EX-10.3
2jro kl557
8 Aug 13
Registration of securities
12:00am
10-12G
EX-3.2
8nkjqk2iytzfxbed0f
8 Aug 13
Registration of securities
12:00am